6622.HK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 11:08):

Stats
Dzisiejszy wolumen	964 145
Średni wolumen	580 496
Kapitalizacja rynkowa	830.13M
EPS	HKD0 ( 2024-03-27 )
Następna data zysków	( HKD0 ) 2024-05-24
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-1.970
ATR14	HKD0.00800 (0.53%)

Zhaoke Ophthalmology Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zhaoke Ophthalmology Finanse

Annual	2023
Przychody:	HKD18.75M
Zysk brutto:	HKD14.25M (75.98 %)
EPS:	HKD-0.710

FY	2023
Przychody:	HKD18.75M
Zysk brutto:	HKD14.25M (75.98 %)
EPS:	HKD-0.710

FY	2022
Przychody:	HKD0
Zysk brutto:	HKD0 (0.00 %)
EPS:	HKD-0.760

FY	2021
Przychody:	HKD0.00
Zysk brutto:	HKD0.00 (0.00 %)
EPS:	HKD-3.98

Financial Reports:

No articles found.

Zhaoke Ophthalmology

Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People's Republic of China. It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China.